Literature DB >> 35581449

Factors Associated with Prescription Drug Monitoring Program Use Among US Physicians: National Electronic Health Record Survey 2018-2019.

Juhan Lee1, Kea Turner2,3, Marwin Groener4, Oliver T Nguyen2, Amir Alishahi Tabriz2,3, Young-Rock Hong5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35581449      PMCID： PMC9585112          DOI： 10.1007/s11606-022-07645-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  5 in total

Review 1.  Barriers and facilitators to PDMP IS Success in the US: A systematic review.

Authors:  Heather D Martin; Shikha S Modi; Sue S Feldman
Journal:  Drug Alcohol Depend       Date:  2020-12-19       Impact factor: 4.492

Review 2.  Prescription drug monitoring programs in the US: A systematic literature review on its strength and weakness.

Authors:  Fahd Alogaili; Norjihan Abdul Ghani; Nordiana Ahmad Kharman Shah
Journal:  J Infect Public Health       Date:  2020-07-18       Impact factor: 3.718

3.  Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.

Authors:  Rivfka Shenoy; Zachary Wagner; Allison Kirkegaard; Robert J Romanelli; Satish Mudiganti; Louis Mariano; Meghan Martinez; Kyle Zanocco; Katherine E Watkins
Journal:  JAMA Health Forum       Date:  2021-10-01

4.  Middle managers' role in implementing evidence-based practices in healthcare: a systematic review.

Authors:  Sarah Birken; Alecia Clary; Amir Alishahi Tabriz; Kea Turner; Rosemary Meza; Alexandra Zizzi; Madeline Larson; Jennifer Walker; Martin Charns
Journal:  Implement Sci       Date:  2018-12-12       Impact factor: 7.327

5.  Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates.

Authors:  Jordan Everson; Audrey K Cheng; Stephen W Patrick; Stacie B Dusetzina
Journal:  JAMA Netw Open       Date:  2020-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.